Today: 16 June 2026

Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials stock snaps 7-day rally as China pushes “50% domestic tools” rule

Applied Materials shares fell 1.2% to $259.97 Tuesday, ending a seven-day rally. Lam Research and KLA also closed lower. Reuters reported China is requiring chipmakers to source at least half of new-fab equipment from domestic suppliers, raising uncertainty for U.S. toolmakers. U.S. granted Samsung and SK Hynix annual licenses for chip equipment shipments to China.
Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis

Reddit stock (RDDT) slips after CTO share-sale filing; traders weigh AI-citation thesis

Reddit shares fell 0.55% to $233.36 after CTO Christopher Slowe sold 14,000 shares for about $3.27 million, according to an SEC filing. Needham maintained a Buy rating and $300 target, citing Reddit’s frequent citations in AI-generated answers. The stock traded between $229.08 and $236.93 on volume of 2.48 million shares. U.S. indexes closed slightly lower as investors reviewed Fed minutes.
31 December 2025
Motorola Solutions stock rises as Wall Street slips in thin trade — MSI investors eye dividend, next earnings window

Motorola Solutions stock rises as Wall Street slips in thin trade — MSI investors eye dividend, next earnings window

Motorola Solutions shares rose 1.77% to $383.94 Tuesday, outperforming a weaker market in thin year-end trading. The stock traded between $375.10 and $384.90 on about 1.5 million shares. Investors await a Jan. 15 dividend payout of $1.21 per share and the next earnings report, expected around Feb. 12. Peers were mixed, with Axon Enterprise down 1.45%.
Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next

Qualcomm stock edges higher in thin year-end trade as Fed minutes land — what to watch next

Qualcomm shares closed up 0.13% at $173.65 Tuesday, outperforming broader markets as the Dow, S&P 500, and Nasdaq all slipped. Trading was thin ahead of year-end, with investors parsing Federal Reserve minutes and watching moves in major tech stocks. Apple fell 0.3% and Nvidia dropped 0.4%. Qualcomm’s next earnings call is set for Feb. 4, 2026.
Lumentum stock slips today as year-end trading thins out — what to watch next for LITE

Lumentum stock slips today as year-end trading thins out — what to watch next for LITE

Lumentum shares closed down 0.4% at $371.19 Tuesday, following a 4.65% drop the previous session. A regulatory filing showed director Thad Trent received 1,205 restricted stock units vesting over time. U.S. stocks finished slightly lower in thin, choppy trade, with technology shares under pressure. The next earnings report for Lumentum is scheduled for Feb. 5, 2026.
31 December 2025
Super Micro (SMCI) stock slips after ops-chief retirement filing; what traders watch next

Super Micro (SMCI) stock slips after ops-chief retirement filing; what traders watch next

Super Micro Computer shares fell 1.4% to $29.65 Tuesday after an SEC filing revealed its operations chief will retire at year-end, with an engineering executive set to take over. The company said outgoing SVP George Kao will stay on as a consultant during the transition. Investors await an amended filing on Kao’s consulting terms and the next quarterly update after Dec. 31. About 21.2 million shares traded hands.
31 December 2025
Applied Digital stock slides after ChronoScale cloud spinout plan with Ekso; APLD traders eye Jan. 7 earnings

Applied Digital stock slides after ChronoScale cloud spinout plan with Ekso; APLD traders eye Jan. 7 earnings

Applied Digital shares fell 2.9% to $24.08 Tuesday after the company announced a non-binding term sheet to combine its cloud unit with Ekso Bionics and form a new company, ChronoScale. The stock traded between $24.03 and $26.33 on heavy volume. Applied Digital’s next earnings report is due Jan. 7.

Stock Market Today

  • Graham Corporation (GHM) Jumps 3.5% on Defense Market Optimism
    June 16, 2026, 10:06 AM EDT. Shares of Graham Corporation (GHM) rose 3.5% to $107.57, driven by strong trading volume and optimism around defense sector momentum. The company benefits from robust demand in naval defense and growth in space programs. Despite expected quarterly earnings per share (EPS) of $0.36, down 20% year-over-year, revenues are projected to increase 20.2% to $66.68 million. However, analysts have cut Graham's EPS estimates by over 20% in the past month, indicating some caution. The stock holds a Zacks Rank #3 (Hold). Industry peer Parker-Hannifin (PH) also saw gains, closing 1.7% higher. Investors should watch for updates as earnings estimates trends often influence near-term stock moves.

Latest articles

Qualcomm Shares Rise on Tenstorrent Deal Talks and AI Push

Qualcomm Shares Rise on Tenstorrent Deal Talks and AI Push

16 June 2026
Qualcomm shares jumped 4.3% to $220.81 after reports it’s in talks to buy AI chip startup Tenstorrent for $8–$10 billion, as investors weigh the potential to diversify beyond smartphones ahead of the June 24 Investor Day, with the stock reflecting both excitement and uncertainty over the possible deal and the company’s AI strategy.
Rigetti Computing Stock Jumps as Quantum Rally Revives RGTI Risk Appetite

Rigetti Computing Stock Jumps as Quantum Rally Revives RGTI Risk Appetite

16 June 2026
Rigetti Computing surged 8.2% to $22.70 on heavy volume as quantum stocks rallied after D-Wave’s price target hike and HPE’s hybrid quantum announcement, but with just $4.4 million Q1 revenue against a $7.6 billion market cap, future growth is already priced in and the next earnings update is the key catalyst for investors.
CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

CervoMed Shares Rise in Early Trade After $3 Million Insider-Related Purchase

16 June 2026
CervoMed soared over 30% premarket after an SEC filing revealed a trust linked to board chair Joshua S. Boger bought $3 million in units above Monday’s close, signaling insider confidence following last week’s $10.5 million private placement that extends cash runway but raises dilution risks; the next key catalyst is securing a strategic partner for neflamapimod’s Phase 3 dementia with Lewy bodies program.
Go toTop